# Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

> **NCT01401023** · NA · COMPLETED · sponsor: **Gary E. Stein, Pharm.D.** · enrollment: 10 (actual)

## Conditions studied

- Diarrhea
- Clostridium Difficile

## Interventions

- **DRUG:** Tigecycline

## Key facts

- **NCT ID:** NCT01401023
- **Lead sponsor:** Gary E. Stein, Pharm.D.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401023, "Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01401023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*